Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
-
- STATUS
- Recruiting
-
- days left to enroll
- 41
-
- participants needed
- 40
-
- sponsor
- University of North Carolina, Chapel Hill
Summary
To assess patient acceptance and preference among screening modalities, Esophagogastroduodenoscopy (EGD), Transnasal Esophagoscopy (TNE), and Cytosponge for Barrett's esophagus (BE). Subjects will undergo administration of Cytosponge and transnasal endoscopy (TNE) prior to their scheduled clinically indicated upper endoscopy performed per routine standard of care. Following the procedure, a follow-up phone call will be made during which an impact of events scale related to the subjective distress of each procedure, a preference and acceptance questionnaire, and adverse events related to study participation will be collected.
Description
Potential subjects will be identified via protocol and Institutional Review Board (IRB) methods prior to obtaining written informed consent. Once written informed consent is obtained and baseline demographic and medical history is collected, subjects will undergo administration of Cytosponge and transnasal endoscopy (TNE) prior to their scheduled clinically indicated upper endoscopy performed per routine standard of care. Following the procedure, a follow-up phone call will be made during which an impact of events scale related to the subjective distress of each procedure, a preference and acceptance questionnaire, and adverse events related to study participation will be collected.
Details
| Condition | gastric reflux, gerd, esophageal reflux, Precancerous condition, Precancerous Conditions, gastroesophageal reflux disease, Barrett's Esophagus, Gastroesophageal Reflux Disease (GERD), BARRETT'S ESOPHAGUS, Esophageal Disorders, gastro-oesophageal reflux, Esophageal Diseases, Gastroesophageal Reflux |
|---|---|
| Treatment | esophagogastroduodenoscopy, Cytosponge, Transnasal Endoscopy (TNE) |
| Clinical Study Identifier | NCT04301986 |
| Sponsor | University of North Carolina, Chapel Hill |
| Last Modified on | 18 September 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer